clinicians Your medication is compounded: prepared for your prescription by a licensed 503A U.S
The recommended starting doses are as follows: For patients nave to basal insulin or to a GLP-1 RA, currently on less than 30 units of basal insulin, or on a GLP-1 RA: Start at 15 units subcutaneously once daily within 60 minutes of the first meal of the day
This guide covers GHK-Cu dosage as documented in the research protocol literature, the difference between injectable and topical dosing approaches, the concentration ranges common in published research, and the reconstitution and timing considerations that affect research outcomes
If you are in mid-to-late titration (4-12mg range), reconstitute at 10mg/mL or 20mg/mL
By following a structured process of assessment, lab work, and professional monitoring, you can safely access the medications needed to support a healthier life